BioRay Pharmaceutical Co Ltd
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From BioRay Pharmaceutical Co Ltd
Around the turn of the year, four Chinese biotechs including Kelun Biotech and BioRay ramped up funding with deals worth more than $100m, at a time when overall investment sentiment in the sector remains gloomy.
Shanghai’s biopharma sector has started to regain momentum and is beginning to see its innovation bets paying off, with support from the local government.
- Other Names / Subsidiaries
- Hisun BioRay Biopharmaceutical Co., Zhejiang Borui Biopharmaceutical Co., Ltd
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.